Technical comment on : Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data

Arber, Caroline; Baerlocher, Gabriela; Chalandon, Yves; Daskalakis, Michael; Duchosal, Michel; Fehr, Martin; Gerull, Sabine; Güngör, Tayfun; Nair, Gayathri; Pabst, Thomas; Passweg, Jakob R; Piccolruaz, Barbara; Renner, Christoph; Ruefer, Axel; Schneidawind, Dominik; Stüssi, Georg; Zeerleder, Sacha; Halter, Jörg P; Swiss Blood Stem Cell Transplant and Cellular Therapies (SBST) group

doi:10.57187/s.3704

Scientific article

Comment

English

Technical comment on : Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data

ContributorsArber, Caroline; Baerlocher, Gabriela; Chalandon, Yves

; Daskalakis, Michael; Duchosal, Michel; Fehr, Martin; Gerull, Sabine; Güngör, Tayfun; Nair, Gayathri; Pabst, Thomas; Passweg, Jakob R; Piccolruaz, Barbara; Renner, Christoph; Ruefer, Axel; Schneidawind, Dominik; Stüssi, Georg; Zeerleder, Sacha; Halter, Jörg P; Swiss Blood Stem Cell Transplant and Cellular Therapies (SBST) group

Published inSwiss medical weekly, vol. 154, 3704

Publication date2024-10-03

First online date2024-10-03

Abstract

Comment on : Trottmann M, Blozik E, Hilbig M, LoVerdi D, Pedruzzi M, Scherer T, Weiss M, Pletscher M, Meier N. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data. Swiss Med Wkly. 2023 Sep 29;153:3441. doi: 10.57187/s.3441. PMID: 37774383.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Leucémie et transplantation allogénique de cellules souches hématopoïétiques (982)

Citation (ISO format)

ARBER, Caroline et al. Technical comment on : Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data. In: Swiss medical weekly, 2024, vol. 154, p. 3704. doi: 10.57187/s.3704